The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intravesical therapy with the trifunctional anti-EpCAM/CD3 bsAb Catumaxomab is well tolerated and shows encouraging preliminary efficacy in patients with high-risk NMIBC (CATUNIBLA phase I trial).
 
Felix Albert
No Relationships to Disclose
 
Aleksander Antoniewicz
No Relationships to Disclose
 
Tobias Grantzow
No Relationships to Disclose
 
Guenter Fingerle-Rowson
Employment - MorphoSys; Tubulis GmbH
Leadership - Tubulis GmbH
Stock and Other Ownership Interests - F. Hoffmann LaRoche; MorphoSys
Consulting or Advisory Role - Lindis Biotech
Patents, Royalties, Other Intellectual Property - I am listed as inventor on 2 patents from MorphoSys AG.
 
Peter Ruf
Employment - Lindis Biotech
Leadership - Lindis Biotech
Patents, Royalties, Other Intellectual Property - Lindis Biotech
 
Horst Lindhofer
Employment - Lindis Biotech
Leadership - Lindis Biotech
Stock and Other Ownership Interests - Lindis Biotech
Patents, Royalties, Other Intellectual Property - Lindis Biotech
Travel, Accommodations, Expenses - Lindis Biotech
 
Maximilian Kriegmair
No Relationships to Disclose
 
Ralph Oberneder
Patents, Royalties, Other Intellectual Property - Bluelife